Laboratorios Richmond SACIF
RICH.BA
| Exchange: | BA |
| Currency | Argentine Peso |
| ISIN: | ARLRIC300027 |
| Primary Ticker: | RICH.BA |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Pharmaceuticals |
| Gic Sub Industry: | Pharmaceuticals |
| Description: | Laboratorios Richmond S.A.C.I.F., a pharmaceutical company, develops and manufactures pharmaceutical products. It provides antiretroviral products for the treatment of human immunodeficiency virus (HIV); oncology and oncohematology drugs; cardiometabolic drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs comprising analgesic, antipsychotic, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company sells its products in Latin America, Africa, Asia, and the Middle East. Laboratorios Richmond S.A.C.I.F. was founded in 1935 and is headquartered in Buenos Aires, Argentina. |
| Address: | Avenida Elcano 4938, Buenos Aires, Argentina, C1427CIU |
| Website: | https://www.richmondlab.com |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 134451257344 |
| Market Capitalization Mln: | 134451.25 |
| EBITDA: | 7486106112 |
| PE Ratio: | 1037.38 |
| Book Value: | 611.84 |
| Earnings Share: | 1.60 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.09 |
| Operating Margin TTM: | 0.13 |
| Return On Assets TTM: | 0.03 |
| Return On Equity TTM: | 0.10 |
| Revenue TTM: | 35582767104 |
| Revenue Per Share TTM: | 440.61 |
| Quarterly Revenue Growth YOY: | 0.01 |
| Gross Profit TTM: | 8859635962 |
| Diluted Eps TTM: | 1.60 |
| Quarterly Earnings Growth YOY: | 22.72 |
Valuation
| Trailing PE: | 1037.38 |
| Price Sales TTM: | 3.77 |
| Enterprise Value: | 243797049344 |
Shares
| Shares Outstanding: | 14167200 |
| Shares Float: | 14167041 |
| Percent Institutions: | 0.58 |
Technicals
| Beta: | 0.22 |
| 52 Week High: | 2160 |
| 52 Week Low: | 595.5 |
Splits & Dividends
| Ex Dividend Date: | 2022-05-09 |
Earnings
| Report Date: | 2023-03-31 |
| Date: | 2023-03-31 |
| Eps Actual: | 0.92 |
| Report Date: | 2022-11-09 |
| Date: | 2022-09-30 |
| Before After Market: | Before Market |
| Currency: | ARS |
| Eps Actual: | -2.14 |
| Report Date: | 2022-08-10 |
| Date: | 2022-06-30 |
| Before After Market: | Before Market |
| Currency: | ARS |
| Eps Actual: | 5.79 |
| Report Date: | 2022-05-11 |
| Date: | 2022-03-31 |
| Before After Market: | Before Market |
| Currency: | ARS |
| Eps Actual: | 2.77 |
| Report Date: | 2021-11-11 |
| Date: | 2021-09-30 |
| Currency: | ARS |
| Eps Actual: | -0.96 |
| Report Date: | 2021-05-12 |
| Date: | 2021-03-31 |
| Currency: | ARS |
| Eps Actual: | -1.22 |
| Report Date: | 2020-09-30 |
| Date: | 2020-09-30 |
| Currency: | ARS |
| Eps Actual: | 1.64 |
| Report Date: | 2020-06-30 |
| Date: | 2020-06-30 |
| Currency: | ARS |
| Eps Actual: | 0.61 |
| Report Date: | 2020-03-31 |
| Date: | 2020-03-31 |
| Currency: | ARS |
| Eps Actual: | -0.23 |
| Report Date: | 2019-09-30 |
| Date: | 2019-09-30 |
| Currency: | ARS |
| Eps Actual: | 0.32 |
| Report Date: | 2019-06-30 |
| Date: | 2019-06-30 |
| Currency: | ARS |
| Eps Actual: | 0.02 |
| Report Date: | 2019-03-31 |
| Date: | 2019-03-31 |
| Currency: | ARS |
| Eps Actual: | -0.84 |
| Date: | 2023-03-31 |
| Eps Actual: | 6.68 |